Skip to main content

Table 2 Comparison of discharge status: dropout or completed by patient characteristics

From: Substance use disorder treatment retention and completion: a prospective study of horse-assisted therapy (HAT) for young adults

Variable

Item

Dropout

Completed

Total

%

Chi square

N = 65

N = 43

N = 108

100

Participation in HAT

No

37 (56.9)

6 (14.0)

43

39.8

19.94, p < 0.001

Yes

28 (43.1)

37 (86.0)

65

60.2

Days in treatment

 Mean

<113 days

50 (76.9)

10 (23.3)

60

55.6

30.18, p < 0.001

113+ days

15 (23.1)

33 (76.7)

48

44.4

 Critical period

<90 days

44 (67.7)

5 (11.6)

49

45.4

32.82, p < 0.001

90+ days

21 (32.3)

38 (88.4)

59

54.6

Gender

Female

16 (24.6)

14 (32.6)

30

27.8

0.81, p = 0.367

Male

49 (75.4)

29 (67.4)

78

72.2

Age

<20 years

12 (18.5)

2 (4.7)

14

13

4.81, p = 0.090

20–26 years

43 (66.2)

31 (72.3)

74

68.5

27+ years

10 (15.4)

10 (23.3)

20

18.5

Years of schooling

<10 years

13 (20.0)

5 (11.6)

18

16.7

1.96, p = 0.376

10–12 years

42 (64.6)

28 (65.1)

70

64.8

13+ years

10 (15.4)

10 (23.3)

20

18.5

Primary substance

Cannabis

23 (35.4)

19 (44.2)

42

38.9

4.75, p = 0.577

Alchol

14 (21.5)

6 (14.0)

20

18.5

Heroin

12 (18.5)

5 (11.6)

17

15.7

Amphetamine

7 (10.8)

8 (18.6)

15

13.9

Benzodiazepine

5 (7.7)

3 (7.0)

8

7.4

GHBa

2 (3.1)

2 (4.7)

4

3.7

Cocaine

2 (3.1)

0 (0.0)

2

1.9

No. of substances

1 substances

20 (30.8)

15 (34.9)

35

32.4

0.15, p = 0.292

2 substances

16 (24.6)

15 (34.9)

31

28.7

3 substances

29 (44.6)

13 (30.2)

42

38.9

Age of first use

<16 years

35 (53.8)

22 (51.2)

57

52.8

0.08, p = 0.785

16+ years

30 (46.2)

21 (48.8)

51

47.2

Substitution medicineb

No

55 (84.6)

37 (86.0)

92

85.2

0.42, p = 0.840

Yes

10 (15.4)

6 (14.0)

16

14.8

HSCL-25c

<1.75

12 (18.5)

7 (16.3)

19

17.6

0.09, p = 0.771

1.75+

53 (81.5)

36 (83.7)

89

82.4

Psych co-morbidity (at entry)

None diagnosed

32 (49.2)

26 (60.5)

58

53.7

2.25, p = 0.325

1 diagnosed

24 (36.9)

10 (23.3)

34

31.5

2+ diagnosed

9 (13.8)

7 (16.3)

16

14.8

Temporary exit

No exit

42 (64.6)

23 (53.5)

65

60.2

1.87, p = 0.393

1 re-entry

14 (21.5)

10 (23.3)

24

22.3

2+ re-entries

9 (13.8)

10 (23.3)

19

17.6

  1. aGamma hydroxybutyrate (C4H8O3)
  2. bOpioid pharmacotherapy
  3. cHopkins Symptom Checklist-25